United Therapeutics Corp. (UTHR)
593.31
-2.35
(-0.39%)
USD |
NASDAQ |
Nov 12, 16:00
593.38
+0.07
(+0.01%)
After-Hours: 20:00
United Therapeutics Free Cash Flow (Quarterly) : 125.80M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 125.80M |
| June 30, 2026 | 202.20M |
| March 31, 2026 | 362.50M |
| December 31, 2025 | 173.30M |
| September 30, 2025 | 346.10M |
| June 30, 2025 | 129.50M |
| March 31, 2025 | 386.30M |
| December 31, 2024 | 254.50M |
| September 30, 2024 | 298.00M |
| June 30, 2024 | 187.10M |
| March 31, 2024 | 338.30M |
| December 31, 2023 | 74.70M |
| September 30, 2023 | 280.50M |
| June 30, 2023 | 61.60M |
| March 31, 2023 | 330.80M |
| December 31, 2022 | 81.20M |
| September 30, 2022 | 189.80M |
| June 30, 2022 | 110.00M |
| March 31, 2022 | 275.20M |
| December 31, 2021 | 104.00M |
| September 30, 2021 | 162.30M |
| June 30, 2021 | 131.90M |
| March 31, 2021 | 79.20M |
| December 31, 2020 | 112.20M |
| September 30, 2020 | 235.10M |
| Date | Value |
|---|---|
| June 30, 2020 | 145.80M |
| March 31, 2020 | 201.60M |
| December 31, 2019 | 77.80M |
| September 30, 2019 | 171.80M |
| June 30, 2019 | 112.60M |
| March 31, 2019 | -652.50M |
| December 31, 2018 | 66.60M |
| September 30, 2018 | 163.00M |
| June 30, 2018 | 126.30M |
| March 31, 2018 | 238.10M |
| December 31, 2017 | -113.60M |
| September 30, 2017 | 236.50M |
| June 30, 2017 | 49.80M |
| March 31, 2017 | 215.20M |
| December 31, 2016 | 148.70M |
| September 30, 2016 | 219.60M |
| June 30, 2016 | 115.30M |
| March 31, 2016 | 116.80M |
| December 31, 2015 | -6.021M |
| September 30, 2015 | 196.87M |
| June 30, 2015 | 37.15M |
| March 31, 2015 | 104.97M |
| December 31, 2014 | 88.32M |
| September 30, 2014 | 194.89M |
| June 30, 2014 | -67.32M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Liquidia Corp. | 129.78M |
| Alnylam Pharmaceuticals, Inc. | 271.15M |
| Exelixis, Inc. | 277.47M |
| Gilead Sciences, Inc. | 4.798B |
| Insmed, Inc. | -42.08M |